Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
277 studies found for:    Cerebral Atrophy
Show Display Options
Rank Status Study
21 Completed Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)
Condition: Alzheimer's Disease
Intervention: Drug: memantine HCl
22 Completed PET Imaging in Chronic Traumatic Encephalopathy
Conditions: Brain Disease;   Brain Mapping
Intervention:
23 Completed Does Glaucoma Cause Loss of Brain Function?
Condition: Glaucoma
Intervention:
24 Recruiting Telmisartan vs. Perindopril in Hypertensive Mild-Moderate Alzheimer's Disease Patients
Conditions: Alzheimer's Disease;   Hypertension
Interventions: Drug: Perindopril;   Drug: Telmisartan
25 Withdrawn Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: 95% Pure ECGC capsules 200mg;   Drug: Placebo Comparator:
26 Unknown  A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
27 Completed Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)
Condition: Multiple Sclerosis, Chronic Progressive
Interventions: Drug: lipoic acid;   Drug: Placebo
28 Recruiting Cohort Study to Investigate the Association Between Changes in Brain Volume and Postoperative Cognitive Dysfunction
Conditions: Postoperative Cognitive Dysfunction;   Delirium;   Dementia
Intervention:
29 Terminated
Has Results
Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II
Condition: Multiple Sclerosis
Interventions: Drug: Polyphenon E;   Other: Placebo
30 Unknown  Automated Brain Morphometry for Dementia Diagnosis
Condition: Dementia
Interventions: Device: Brain Morphometry;   Other: Standard radiological assessment
31 Withdrawn Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life
Condition: Multiple Sclerosis
Intervention:
32 Recruiting DANish DELIrium Study On Neurointensive Care Patients
Conditions: Acquired Brain Injuries;   Delirium;   Acute Brain Injury
Intervention: Other: intervention bundle (sedation, pain, mobilization and sleep)
33 Recruiting The Microvascular Brain Retina And Kidney Study
Condition: Cerebral Small Vessels Disease
Intervention:
34 Withdrawn Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment
Condition: Alzheimer's Disease
Interventions: Drug: CHF 5074 1x;   Drug: CHF 5074 2x;   Drug: Placebo
35 Unknown  Study of MRI 3Tesla Infusion Without Arterial Spin Labeling Injection (ASL) in Cognitive Atypical and Comparison to the FDG-PET
Condition: Atypical Cognitive Disorders
Intervention:
36 Completed Magnetic Stimulation Therapy for Treating Vascular Depression
Conditions: Depressive Disorder;   Depression
Interventions: Procedure: Repetitive transcranial magnetic stimulation (rTMS);   Drug: Citalopram;   Procedure: Sham rTMS
37 Completed
Has Results
Progression Delaying Effect of Escitalopram in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: escitalopram;   Drug: placebo
38 Not yet recruiting MRI Markers of Outcome After Severe Pediatric TBI
Condition: Brain Injuries
Intervention: Other: MRI Scans
39 Completed Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
Conditions: Relapsing-Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis
Interventions: Drug: natalizumab;   Other: standard of care
40 Active, not recruiting Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Biological: natalizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.